ALDH18A1 and breast carcinoma: A meta-analysis combining all datasets from previous and current studies confirmed that Gp-R was a significant predictor of pCR across all breast cancer subtypes (OR = 5.24, 95% CI 4.00–6.85, Fig. 1A).